Sio Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Sio Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,310	Closed	-$411K	–	74
2019 Q3	$411K	Hold	20,310	–	–	0.13%	59
2019 Q2	$523K	Sell	20,310 -22,100	-52%	-$443K	0.13%	68
2019 Q1	$603K	Sell	42,410 -338,402	-89%	-$3.14M	0.16%	64
2018 Q4	$1.07M	Sell	380,812 -35,646	-9%	-$117K	0.39%	58
2018 Q3	$1.44M	Buy	416,458 +223,168	+115%	+$661K	0.49%	51
2018 Q2	$619K	Hold	193,290	–	–	0.34%	44
2018 Q1	$474K	Buy	+193,290	New	+$579K	0.28%	30
2017 Q3	–	Sell	-160,000	Closed	-$880K	–	57
2017 Q2	$880K	Sell	160,000 -50,000	-24%	-$209K	0.42%	50
2017 Q1	$819K	Buy	+210,000	New	+$1M	0.46%	39

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sio Capital Management's AXSM Position: Q4 2019 in Review

Sio Capital Management sold out of Axsome Therapeutics (AXSM) in Q4 2019, closing a stake of 20,310 shares — an estimated $411K sold.

Sio Capital Management first reported a position in AXSM in Q1 2017 and held it in 9 quarters. The position peaked at $1.44M in Q3 2018. 169 funds tracked by Wall St. Rank hold AXSM as of Q4 2019.

Sio Capital Management reported no remaining Axsome Therapeutics position as of Q4 2019 after selling out during the quarter.
Sio Capital Management sold 20,310 Axsome Therapeutics shares in Q4 2019, an estimated $411K.
Sio Capital Management first reported a position in Axsome Therapeutics in Q1 2017 and held it in 9 quarters.
Sio Capital Management's Axsome Therapeutics position peaked at $1.44M in Q3 2018.
169 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2019.

Based on Sio Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.